Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial – The Lancet Respiratory Medicine News Releases: Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination – University […]

The post RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine. appeared first on Links Medicus.